May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Intravitreal Concentration of Sub–Tenon’s Injected Triamcinolone Acetonide
Author Affiliations & Notes
  • E. Thomas
    Dept Ophthalmology, Mason Eye Inst/Univ MO–Columbia, Columbia, MO
  • D.P. Hainsworth
    Dept Ophthalmology, Mason Eye Inst/Univ MO–Columbia, Columbia, MO
  • Footnotes
    Commercial Relationships  E. Thomas, None; D.P. Hainsworth, None.
  • Footnotes
    Support  Research to Prevent Blindness, New York, NY.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 5394. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Thomas, D.P. Hainsworth; Intravitreal Concentration of Sub–Tenon’s Injected Triamcinolone Acetonide . Invest. Ophthalmol. Vis. Sci. 2005;46(13):5394.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Sub–tenon’s injection of steroid has been a mainstay of treatment of intraocular inflammation. Recently, intravitreal steroid injection has been proposed for treatment of inflammation and edema. Although sub–tenon’s injection has been used for many years the concentration of triamcinolone entering the vitreous cavity is unknown. Knowledge of the penetration of triamcinolone following sub–tenon’s injection would allow comparison to known concentrations of intravitreal injections. Methods: 20 patients undergoing vitreous surgery received a 40mg injection of triamcinolone acetonide in the posterior sub–tenon’s space. Undiluted vitreous obtained at the time of surgery was evaluated by HPLC for steroid concentration. Intravitreal concentration at differing time durations from injection to time of surgery was plotted. Initial drug concentration was calculated. Results: Drug concentration ranged from 0.02 to 4.9 µg/ml with time durations between injection and vitreous removal ranging from 1 to 29 days. Calculated average initial drug concentration was 0.24 µg/ml. Conclusions: A wide range of vitreous concentration of triamcinolone acetonide is found following sub–tenon’s injection.

Keywords: vitreous • drug toxicity/drug effects • vitreoretinal surgery 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.